Connect with us

Pennsylvania

4 things to watch for in the Pennsylvania GOP Senate Debate

Published

on

4 things to watch for in the Pennsylvania GOP Senate Debate


(WHTM) – For the primary time, we’re concerning the see the GOP frontrunners vying to switch retiring Republican U.S. Senator Pat Toomey debate in primetime.

In a race anticipated to assist decide the stability of energy within the Senate, former hedge fund CEO Dave McCormick and superstar doctor Mehmet Oz are on the prime of the polls. The Monday night debate shall be a possibility for voters to see how the pair differs, if in any respect, on key points. It’ll even be a possibility for commentator Kathy Barnette, businessman Jeff Bartos, and former former U.S. Ambassador Carla Sands to make an impactful impression with potential voters.

The controversy will air at 8pm and be televised in all 67 counties within the Keystone State. It’ll be out there nationally through livestream.

In an early April ballot, McCormick had the assist of 18% of doubtless GOP voters whereas Oz was proper behind him at 17%. Barnette completed third with 10% within the WHTM/Emerson School Polling/The Hill Pennsylvania main ballot adopted by Bartos at 9% and Sands at 8%.

Advertisement

George Bochetto and Sean Gale earned underneath 5% of assist. Candidates who acquired a minimum of 5% within the ballot certified for the Monday debate hosted by Nexstar Media Inc. and our media companions, WPXI-TV in Pittsburgh.

Listed here are 4 issues we’ll be awaiting underneath the studio lights in Harrisburg on Monday:

How will Oz defend his TV present statements?

Since former U.S. President Donald Trump’s endorsement of Oz, McCormick’s marketing campaign and supporters have used clips and previous feedback from Oz’s TV present to color him as left-leaning.

The final time McCormick and Oz shared the identical stage, McCormick claimed feedback on the “Dr. Oz Present” and different writings confirmed Oz referred to as for extra fracking regulation. Oz denied the declare throughout a discussion board hosted by the Producer & Enterprise Affiliation calling it “a lie.”

Different feedback from Oz’s previous have been put within the highlight together with statements on abortion, gun legal guidelines, and Black Lives Matter.

Advertisement

It’s doubtless Oz will use any questions on whether or not he’s conservative sufficient to be the nominee to remind voters he earned Trump’s endorsement over the opposite candidates within the race.

Apparently sufficient, an advert presently on airwaves and featured on the McCormick marketing campaign web site exhibits bikers behind McCormick prominently displaying pro-Trump flags.

Can the outsiders show they will join with Pennsylvanians?

Previous to this race, each of the frontrunners had their main residences in different states. McCormick lived in Connecticut and Oz’s residence was in New Jersey.

Oz attended the College of Pennsylvania’s Faculty of Medication after rising up in Wilmington, Delaware. He’s lived in New Jersey for the final 20 years, in keeping with goerie.com.

Go Erie reviews Oz began voting in Pennsylvania through absentee poll in 2021 utilizing his in-laws’ Philadelphia-area handle.

Advertisement

Whereas McCormick might have beforehand lived in Fairfield, Connecticut, he grew up within the Columbia County city of Bloomsburg. He considers his candidacy a return residence.

McCormick’s dad and mom stay simply exterior Harrisburg, in keeping with pennlive.com.

Whereas residing in Connecticut, McCormick labored at Bridgewater Associates. Earlier than that, he had a place with President George W. Bush’s administration.

Each candidates have flooded tv and social media with video and pictures of them on the bottom within the state interacting with Pennsylvanians.

Will a candidate decrease within the polls be capable of hit a house run?

Throughout Thursday’s debate with the Democratic candidates within the race, many social media customers felt Malcolm Kenyatta had a standout efficiency. His title was trending on Twitter as the talk got here to an in depth. Behind a minimum of 7% within the polls, Barnette, Bartos, and Sands shall be hoping for related robust performances to achieve assist and lift further marketing campaign funds.

Advertisement

Bartos has beforehand labeled his frontrunner opponents as “political vacationers.” Bartos is an actual property developer.

Barnette made headlines throughout a latest discussion board after calling Oz a “liberal.” She’s a conservative political commentator.

Sands served because the U.S. ambassador to Denmark in the course of the Trump administration. It’s price noting Oz gained Trump’s endorsement over Sands.

How will the candidates act on the identical stage?

This would be the first time these 5 candidates have appeared on the identical stage in a debate format.

In protection of a earlier discussion board that includes 4 of the candidates, Bloomberg’s Mark Niquette famous the moderator needed to try to achieve management over parts of the session. He additionally wrote Oz complained concerning the discussion board’s guidelines not being adopted.

Advertisement

As was the case in Thursday’s Democratic debate, all members have agreed to the principles and solutions shall be timed and people instances enforced. Whereas fireworks are anticipated, moderators Dennis Owens of WHTM and Lisa Sylvester of WPXI will do every little thing they will to maintain the candidates in line and the dialog transferring.

The first election for U.S. Senator from Pennsylvania is scheduled to happen on Could 17. Voters should register to vote by Could 2.





Source link

Advertisement
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Pennsylvania

Biden kills U.S. Steel deal; what Trump said and what it means for Pennsylvania

Published

on

Biden kills U.S. Steel deal; what Trump said and what it means for Pennsylvania


play

President Joe Biden’s decision to block Nippon Steel’s bid to buy U.S. Steel could have significant implications for Pennsylvania and the steel industry.

Advertisement

President-elect Donald Trump had already said he would kill the deal when he takes office later this month to keep a foreign firm from taking over the Pittsburgh-based business.

U.S. Steel employs thousands across its plants and offices in Pennsylvania and the state has about 10% of the nation’s steelworkers.

For them, Biden’s intervention could mean short-term job stability, as the administration emphasizes keeping the company under American ownership. 

But, it’s not a fix for U.S. Steel’s problems; the company has said it needs financial resources to upgrade plants and keep pace with demand for steel around the world.

Biden on Friday issued the order blocking Nippon Steel Corp.’s proposed $14.9 billion purchase of U.S. Steel, citing his presidential authority under the Defense Production Act of 1950 and calling the steel industry “critical for resilient supply chains.”

Advertisement

Nippon and U.S. Steel, however, took exception to the order.

In a joint statement, U.S. Steel and Nippon Steel said it was “dismayed” by Biden’s decision, calling it “a clear violation of due process and the law governing CFIUS.” 

The companies said blocking the sale will deny billions of dollars in investments planned in the U.S. and vowed to take “all appropriate action to protect our legal rights.”

(This story was updated to add new information.)

Advertisement



Source link

Continue Reading

Pennsylvania

Prominent Trump fundraiser enters Pa. GOP chairman race amid pushback to Sen. Rothman

Published

on

Prominent Trump fundraiser enters Pa. GOP chairman race amid pushback to Sen. Rothman


Electors take a group photo after the end of proceedings. Pennsylvania’s electors cast their votes for President-elect Donald Trump and Vice President-elect JD Vance in the chambers of the state House of Representatives at the Capitol in Harrisburg, Pa.
December 17, 2024.
Dan Gleiter | dgleiter@pennlive.comDan Gleiter | dgleiter@pennlive.com



Source link

Continue Reading

Pennsylvania

Penn expecting $467M windfall from COVID-19 vaccine royalty dispute

Published

on

Penn expecting 7M windfall from COVID-19 vaccine royalty dispute


Penn Medicine researchers Katalin Karikó Ph.D., and Dr. Drew Weisman Ph.D., won the 2023 Nobel Prize in Medicine for their work on mRNA technology that contributed to the COVID-19 vaccine research.

Patents typically last about 20 years. The university holds at least four patents for its mRNA technology across the United States and Europe.

Researcher Karikó, an adjunct professor at Penn Medicine for 36 years, worked as a senior vice president for BioNTech between November 2013 and October 2022, according to her LinkedIn profile. She is considered an external consultant for the company as of Jan. 2, according to its website.

The COVID-19 vaccine, also known as Comirnaty, generated about $5 billion in sales in 2024.

Advertisement

As part of the deal, pharmaceutical giant Pfizer is expected to chip in $170 million for the Penn royalties and $364 million towards the NIH royalties owed.

As a company, BioNTech generated about $3.9 billion in revenue during 2023, down from $17.7 billion in 2022. BioNTech estimated 2024 revenue to be between $2.7 billion and $3.3 billion.

The university licensed its mRNA patents to several companies between April 2010 and August 2020, including Epicentre Technologies Corp., mRNA Biotherapeutics Inc. and Cellscript.

In 2017, BioNTech sublicensed the university mRNA technology from Cellscript and expects to keep developing more pharmaceutical medications, such as cancer treatments and flu vaccines, using the university patented technology.

Licensing revenue at the University of Pennsylvania has been a substantial revenue stream for the Philadelphia institution since the COVID-19 pandemic began.

Advertisement

In fiscal 2021, the university collected $300 million in license revenue. In fiscal years 2022 and 2023, the university garnered $1 billion each year. During fiscal year 2024, it reported $466 million in licensing revenue.

In May 2024, Penn Medicine researchers developed an mRNA vaccine for the H5N1 avian flu, leveraging prior COVID-19 vaccine research. The research was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health and the Department of Health and Human Services.

The Duke University Human Vaccine Institute was awarded $7 million from the federal health agencies to conduct clinical trials in early 2025.

But for the commercialization of such research, the university relies on pharmaceutical manufacturers to license such patents and take the drug to market.

It was not immediately clear which companies, if any, have licensed the experimental avian flu technology.

Advertisement



Source link

Continue Reading

Trending